标签归档：nicotinic

Nicotinamide Hydrochloride (Synonyms: Niacinamide Hydrochloride; Nicotinic acid amide Hydrochloride)

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白、同位素标记物，专注于信号通路和疾病研究领域。
Nicotinamide Hydrochloride  (Synonyms: Niacinamide Hydrochloride; Nicotinic acid amide Hydrochloride)

Nicotinamide Hydrochloride 是维生素 B3 或烟酸的一种形式。Nicotinamide Hydrochloride 可抑制 SIRT2 的活性，其 IC50 值为 2 μM。Nicotinamide Hydrochloride 也抑制 SIRT1。Nicotinamide Hydrochloride 增加细胞内 NAD+、ATP、ROS 水平。Nicotinamide Hydrochloride 抑制肿瘤生长并提高生存率。Nicotinamide Hydrochloride 还具有抗-HBV 活性。

Nicotinamide Hydrochloride (Synonyms: Niacinamide Hydrochloride; Nicotinic acid amide Hydrochloride)

Nicotinamide Hydrochloride Chemical Structure

CAS No. : 25334-23-0

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Nicotinamide Hydrochloride 的其他形式现货产品:

Nicotinamide

Nicotinamide Hydrochloride 相关产品

•同靶点产品:

•同靶点蛋白产品:

生物活性

Nicotinamide Hydrochloride is a form of vitamin B3 or niacin. Nicotinamide Hydrochloride inhibits SIRT2 activity (IC50: 2 μM). Nicotinamide Hydrochloride also inhibits SIRT1. Nicotinamide Hydrochloride increases cellular NAD+, ATP, ROS levels. Nicotinamide Hydrochloride inhibits tumor growth and improves survival. Nicotinamide Hydrochloride also has anti-HBV activity[1][2][3][4].

IC50 & Target[1][2]

Human Endogenous Metabolite

 

SIRT2

2 μM (EC50)

SIRT1

50-180 μM (IC50)

体外研究
(In Vitro)

Nicotinamide Hydrochloride (0-50 mM，24/48 小时) 以时间依赖性和剂量依赖性方式减少 A375 和 SK-MEL-28 细胞中的细胞数量[1]。
Nicotinamide Hydrochloride (10-50 mM, 24 h ) 使 A375 细胞在 G1 期积累，在 S 期减少，在亚 G1 期 (细胞凋亡)增加[1]。
Nicotinamide Hydrochloride (1-50 mM，6 小时) 增加 A375 和 SK-MEL-28 细胞中的 NAD+、ATP 和 ROS 水平[1]。
Nicotinamide Hydrochloride (0.01-20 mM，1 小时) 在体外抑制纯化的 SIRT2 酶活性，EC50 为 2 μM[1]。
Nicotinamide Hydrochloride (0-64 mM) 抑制 HBV 在 HepAD38 和 HepG2.2.15 细胞中的复制[3]。
Nicotinamide Hydrochloride (10 mM，第 13 天) 通过抑制 CK1 和 ROCK 促进胰腺细胞从人胚胎干细胞 (hESC) 分化[4]。

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

Nicotinamide Hydrochloride 相关抗体:

Cell Viability Assay[1]

Cell Line: A375, SK-MEL-28, mouse B16-F10 cell
Concentration: 0, 1, 20, 50 mM
Incubation Time: 24 h, 48 h
Result: Reduced cell number in a dose-dependent manner with a strong inhibitory effect at 20mM and an almost complete effect at 50 mM.

Cell Cycle Analysis[1]

Cell Line: A375, SK-MEL-28
Concentration: 10, 20, 50 mM
Incubation Time: 24 h
Result: Arrested A375 cells in G1 phase.

体内研究
(In Vivo)

Nicotinamide Hydrochloride (腹腔注射，1500 和 1800 mg/Kg，每周 5 天) 抑制小鼠转移性黑色素瘤模型中的肿瘤生长[1]。
Nicotinamide Hydrochloride (腹腔注射，1800 mg/Kg，每天一次，小鼠转移性黑色素瘤模型) 影响 IFN-γ (细胞介导的抗肿瘤免疫的关键介质)，增加 Eotaxin 和 IL-5 的血浆水平，降低 IL-3、IL-12、RANTES 和 IL-10 的血浆水平[1]。
Nicotinamide Hydrochloride (静脉注射，0-200 mg/kg，5 天) 抑制 HBV 转基因小鼠体内的 HBV 复制[3]。

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6 mice (subcutaneous injected with B16-F10 cells)[1]
Dosage: 1000, 1500, 1800 mg/Kg.
Administration: Intraperitoneal injection, 5 days per week (followed by 2-day rest) or once a day.
Result: Inhibited tumor growth at 1500 and 1800 mg/Kg, and had no effect on the body weight.
Increased the frequency of IFN-γ producing cells and modulated the protein levels of cytokines and chemokines in the plasma of tumor-bearing mice.
Animal Model: HBV-transgenic mice[3]
Dosage: 0-200 mg/kg
Administration: Vein injection, 5 days
Result: Reduced serum HBV DNA.

Clinical Trial

分子量

158.59

Formula

C6H7ClN2O
CAS 号

25334-23-0
结构分类
  • Alkaloids
  • Pyridine Alkaloids
初始来源
  • 内源性代谢物
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
纯度 & 产品资料
Data Sheet (540 KB) 产品使用指南 (1538 KB)

参考文献

  • [1]. Francesca Scatozza, et al. Nicotinamide inhibits melanoma in vitro and in vivo. J Exp Clin Cancer Res. 2020 Oct 7;39(1):211.  [Content Brief]

    [2]. Hwang ES, et al. Nicotinamide is an inhibitor of SIRT1 in vitro, but can be a stimulator in cells. Cell Mol Life Sci. 2017 Sep;74(18):3347-3362.  [Content Brief]

    [3]. Li WY, et al. The SIRT1 inhibitor, nicotinamide, inhibits hepatitis B virus replication in vitro and in vivo. Arch Virol. 2016 Mar;161(3):621-30.  [Content Brief]

    [4]. Zhang Y, et al. Nicotinamide promotes pancreatic differentiation through the dual inhibition of CK1 and ROCK kinases in human embryonic stem cells. Stem Cell Res Ther. 2021 Jun 25;12(1):362.  [Content Brief]

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务